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Abstract:    A  new  ent-kaurane  diterpenoid  was  isolated  from  the  ethanol  extract  of  Euphorbia  hirta,  and 
elucidated as 2β,16α,19-trihydroxy-ent-kaurane (1), along with two known ent-kauranes, 2β,16α-dihydroxy-ent-
kaurane (2) and 16α,19-dihydroxy-ent-kaurane (3). Their structures were elucidated on the basis of spectroscopic 
analysis including 1D and 2D NMR techniques and HRESIMS evidence. 
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1. Introduction 
 
Euphorbia  is  the  largest  genus  in  the  family  of  Euphorbiaceae,  comprising  about  2000 
species. More than 80 of them are distributed in China [1]. Many secondary metabolites with specific 
types  of  diterpene  skeletons  in  this  genus  have  been  found  to  possess  a  number  of  interesting 
biological activities [2-4]. Euphorbia hirta Linn, mainly distributed in the southern and southwestern 
district  of  China  [5],  has  been  used  traditionally  for  the  treatment  of  gastrointestinal  disorders 
(diarrhea, dysentery, intestinal parasitosis), conjunctivitis, and respiratory diseases (asthma, bronchitis, 
hay fever) [6,7]. Previous phytochemical studies have reported six diterpenoids of abietane, ingenane 
and tigliane-types  from the species [8,9]. On the course of our search for diterpenoids from Euphorbia 
hirta, a new ent-kaurane diterpenoid, 2β,16α,19-trihydroxy-ent-kaurane (1), as well as two known ent-
kauranes (2 and 3) were obtained. Among them, compounds 2 and 3 were the first examples as natural 
products, and NMR data for 2 have not been reported so far. In this paper, we present the isolation and 
structural elucidation of the new compound (1) and the NMR data of 2. 
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2.  Materials and Methods  
2.1. General procedures 
Optical rotations were measured using a Perkin-Elmer model 241 polarimeter. UV 
spectra were carried out on a Shimadzu UV-2401A spectrophotometer. IR spectra were recorded on a 
Bio-Rad FTS-135 spectrometer with KBr pellets. 1D and 2D NMR spectra were measured on a Bruker 
DRX-500 instrument with TMS as internal standard. Mass spectra were obtained on a VG Auto Spec-
3000 spectrometer or on a Finnigan MAT 90 instrument. Column chromatography was performed on 
silica  gel  (200–300  mesh;  Qingdao  Marine  Chemical  Inc.),  the  Sephadex  LH-20  (25-100  µm, 
Pharmacia Fine Chemical Co. Ltd.), and MCI-gel CHP 20P (75–150 µm, Mitsubishi Chemical Corp.). 
Thin-layer  chromatography  (TLC)  was  carried  out on  silica  gel  60  F254  on  glass  plates  (Qingdao 
Marine Chemical Inc.) using various solvent systems. 
2.2 Plant Material  
The  material  of  plant  (Euphorbia  hirta)  was  collected  in  the  Xishuang  Banna  prefecture, 
Yunnan  Province,  People's  Republic  of  China,  in  September  2009.  A  voucher  specimen  (YTCM 
20090909) was deposited at the Yunnan Traditional Chinese Medical College, and was identified by 
Prof. Yao-wen Yang.  
2.3 Extraction and Isolation 
Dry  herbs  of  Euphorbia  hirta  (4.0  kg)  were  extracted  with  ethanol  (3  ×  25  L)  at  room 
temperature overnight. The extract was partitioned between H2O and EtOAc, and an EtOAc layer (58 
g) was chromatographed on MCI-gel CHP 20P (eluted with 90% CH3OH–H2O, then 100% CH3OH). 
The 90% CH3OH fraction (32 g) was repeatedly chromatographed over silica gel eluted in a step 
gradient manner with petroleum ether–acetone (1:0 to 0:1) to afford fractions A–F. Separation of 
fraction A (4 g) by silica gel column chromatography, eluted with petroleum ether-EtOAc (99:1→1:1), 
yielded fractions A1–A4. Compounds 2 (2 mg) and 3 (3 mg) were obtained  from fraction A1 by 
repeated chromatography over silica gel with petroleum ether–EtOAc (49:1). Fraction B (5 g) was 
separated by silica gel column chromatography, eluted with petroleum ether-EtOAc (49:1→1:0), and 
yielded fractions B1–B4. Fraction B3 afforded compound 1 (2 mg) by chromatography over silica gel 
with petroleum ether–EtOAc (9:1) and the Sephadex LH-20 column chromatography (100% MeOH). 
 
3.  Results and Discussion 
Compound  1  was  obtained  as  white  powder  with  [α]
16.1 
D -60.79
 (c=  0.16,  MeOH),  and  its 
molecular formula was determined to be C20H34O3 by HRESIMS data (345.2413 [M + Na]
+, calcd 
345.2405). IR absorptions at 3386 cm
-1 indicated the presence of hydroxyl group and UV absorption at 
202 nm revealed the absence of unsaturated moiety. The 
13C NMR spectrum of 1 (Table 1) displayed 
20 carbon signals corresponding to three methyls, nine methylenes, four methines and four quaternary 
carbons, which was assigned to be a diterpenoid skeleton. The diagnostic signals of three methines [δC 
57.6 (C-5), 58.5 (C-9) and 49.0 (C-13)] and three quaternary carbons [δC 41.5 (C-4), 46.3 (C-8) and 
41.9  (C-10)]  indicated  ent-kaurene  skeleton  of  the  diterpenoid.  The  COSY  spectrum  showed  the 
presence of three proton sequences of -CH2 (1)-CH (2)-CH2 (3)-, -CH (5)-CH2 (6)-CH2 (7)- and -CH 
(9)-CH2 (11)-CH2 (12)-CH (13)-CH2 (14)-, as shown in Figure 2. An oxygenated methylene (δH 3.62 
and 3.32, each 1H, d, J=11.2 Hz; δC 65.7), an oxygenated methine (δH 3.87, 1H, m; δC 65.0) and an 
oxygenated quaternary carbon (δC 79.7) observed in the 
13C
 NMR spectrum were located at C-19, C-2 
and C-16, respectively, which was supported by the HMBC correlations from H-19 to C-4, C-5 and C-
18, from H-2 to C-4 and C-10 and from H-12, H-14, H-15 and CH3-17 to C-16 (Figure 2). In addition, 249                                                 ent-Kaurane diterpenoids 
 
the  shifts  of  C-2  were  agreement  with  those  of  the  known  compound  ent-2α-hydroxy-8(14),15-
pimaradiene [10]. These considerations helped in assigning the planar structure of 1 to be 2,16,19-
trihydroxy-ent-kaurane. 
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Figure 1. The structures of compounds 1-3 
The relative configuration of compound 1 was established on the basis of ROESY correlations 
of H-2 with H-19 and Me-20, H-19 with Me-20, Me-17 with H-12β, H-12β with H-9β as well as 16-
OH with H-13α as shown in computer-generated 3D drawing (Figure 2), which suggested the 2-OH 
and 16-OH possess β and α-orientations, respectively. Moreover, the presence of 19-OH was proved 
by the downfield shift of C-5 (δC 57.6) owing to the absence of a γ-steric compression effect between 
18β-OH  and  H-5.  Thus,  compound  1  was  unambiguously  identified  as  2β,16α,19-trihydroxy-ent-
kaurane. 
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Figure 2. Key HMBC, COSY and ROESY correlations of compound 1 
Compounds 2 and 3 were identified according to the NMR and MS as well as comparison with 
values from the literature [11]. 
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Table 1. 
1H-NMR and 
13C-NMR data of compounds 1 and 2 in CD3OD 
a 
       1                2 
Position 
1H-NMR                      
13C-NMR  Position 
1H-NMR                        
13C-NMR 
1α 
1β 
2α 
3α 
3β 
4 
5β 
6 
7α 
7β 
8 
9β 
10 
11 
12 
13α 
14α 
14β 
15 
16 
17 
18 
19 a 
19 b 
20 
2.17, m                          50.5 (CH2) 
0.68, t, J=11.2 Hz 
3.87, m                          65.0 (CH) 
2.13, m                          46.3 (CH2) 
0.82, t, J=11.0 Hz 
   -                                   41.5 (C) 
0.93, d, J=10.8 Hz        57.6 (CH) 
1.68, m                         21.3 (CH2)  
1.64, overlap                43.5 (CH2) 
1.45, m 
    -                                  46.3 (C) 
1.05, d, J=4.8 Hz          58.5 (CH) 
     -                                 41.9 (C) 
1.64, overlap                 19.3 (CH2) 
1.63, overlap                 27.7 (CH2) 
1.83, br s                       49.0 (CH) 
1.87, d, J=11.6 Hz         38.4 (CH2) 
1.60, overlap 
1.54, s                           58.5 (CH2) 
   -                                   79.7 (C) 
1.33, s                            24.4 (CH3) 
0.99, s                            28.1 (CH3) 
3.62, d, J=11.2 Hz         65.7 (CH2) 
3.32, d, J=11.2 Hz 
1.08, s                            19.9 (CH3) 
1α 
1β 
2α 
3α 
3β 
4 
5β 
6 
7α 
7β 
8 
9β 
10 
11 
12 
13α 
14α 
14β 
15 
16 
17 
18 
19 
   20 
 
2.16, br d, J=11.0 Hz        52.0 (CH2) 
0.65, t, J=11.0 Hz 
3.86, m                              65.5 (CH) 
2.14, br d, J=11.4 Hz        50.4 (CH2) 
1.83, br s                
  -                                        35.7 (C) 
0.80, d, J=11.8 Hz            57.1 (CH) 
1.46, m                              21.2 (CH2) 
1.62, overlap                     43.1 (CH2) 
1.47, m 
    -                                      46.2 (C) 
1.05, d, J=4.9 Hz              58.3 (CH) 
  -                                        42.1 (C) 
1.60, overlap                     19.2 (CH2) 
1.59, overlap                     27.9 (CH2) 
3.30, t, J=1.4 Hz               49.0 (CH) 
1.89, d, J=11.6 Hz            38.6 (CH2) 
1.58, overlap 
1.53, s                               58.7 (CH2) 
   -                                       79.8 (C) 
1.36, s                               24.5 (CH3) 
0.86, s                               34.2 (CH3) 
0.92, s                               22.8 (CH3) 
1.09, s                               19.4 (CH3) 
 
aThe assignments are based on DEPT, HSQC and HMBC experiments. 
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